March 2022 FDA Recall Drug by Golden State Medical Supply Inc.
D-0654-2022 - CGMP Deviation
This Class II drug recall was voluntarily initiated by Golden State Medical Supply Inc. on March 2, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviation. The product was distributed in Distributed to 1 wholesaler/distributor and the recall is currently terminated.
Recall Number: D-0654-2022
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
03-02-2022
03-23-2022
401 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Golden State Medical Supply Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed to 1 wholesaler/distributor
09-13-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
Batch or Lot Expiration Information
Lot# : GS027852, Expiry: 06/2022.